healthcare
India's PE-backed Dr Lal PathLabs files for IPO
Indian medical diagnostic service chain Dr. Lal PathLabs has filed for an IPO, providing part exits for its PE backers WestBridge Crossover Fund and TA Associates.
Carlyle buys stake in India's Metropolis Healthcare
The Carlyle Group has agreed to buy a 37% stake in medical diagnostics chain Metropolis Healthcare, ending a dispute among the company's current ownership.
Baidu leads $40m round for China healthcare site
Chinese search engine Baidu has led a $40 million Series B round for Quyiyuan.com, a Shanghai-based medical consultation and service-booking mobile app.
Tencent, Yunfeng back China social-networking site for doctors
Tencent Holdings and Yunfeng Capital have committed $40 million in a Series B round of funding to Medlinker, a Chinese social-networking platform for doctors.
CITIC Capital appoints healthcare specialist
CITIC Capital Partners has appointed Haipeng Zhang as a senior managing director, with the intent of focusing on healthcare investments.
FountainVest backs China iKang Healthcare’s take-private
Chinese healthcare services provider iKang Healthcare Group has accepted a take-private offer from its founder in collaboration with FountainVest Partners.
IHH buys PE-backed Global Hospitals for $194m
IHH Healthcare has agreed to buy India's Ravindranath GE Medical (RGE), which operates five hospitals under the Global Hospitals brand, for INR12.8 billion ($194 million) in cash.
Shanghai Pharma establishes $469m healthcare fund
Chinese drug maker Shanghai Pharmaceuticals Group has partnered with Shanghai Real Power Capital to launch a healthcare-focused fund with a target of RMB3 billion ($469 million).
IDG, JD in $174m round for Shanghai Pharma’s e-commerce unit
Chinese online retailer JD.com and IDG Capital Partners have participated in a RMB1.11 billion ($174 million) Series A round of funding for Shanghai Pharmaceuticals’ online drug distribution platform.
China cancer diagnostics firm Burning Rock raises $23m
Burning Rock Biotech, a Chinese cancer diagnostic start-up, has raised RMB150 million ($23 million) in an extended Series A round of funding from Ji Feng Capital, Sequoia Capital and Legend Star.
China’s cancer drug developer Ascentage secures $15m
Ascentage Pharma Group, a Shanghai-based cancer drug developer, has raised a RMB95 million ($15 million) Series A round of funding led by Oriza Seed and YuanMing Capital.
China’s CASH Capital targets $193m for Fund II
CASH Capital, the venture capital arm of the state-owned Chinese Academy of Sciences Holdings (CASH Holdings), is seeking to raise RMB1.2 billion ($193 million) for its second renminbi-denominated venture fund.
Nanjing Xinjiekou to buy KKR-backed China Cord Blood
Shanghai-listed Nanjing Xinjiekou Department Store has made a bid to acquire China Cord Blood Corporation (CCBC), a US-listed blood bank operator backed by KKR, for about RMB6 billion ($966 million).
Tencent leads $90m round for India's Practo
Tencent has led a $90 million Series C round for Indian clinic management developer and doctor search portal Practo, with participation from Sofina, Google Capital, and others.
China mobile health solutions provider raises $36m
Shanghai KingYee, a Chinese mobile healthcare services provider, has completed a RMB221 million ($36 million) Series C round of funding led by Sensegain Investment. SoftBank China Venture Capital (SBCVC) and HighLight Capital also participated.
Hopu, YuanMing lead $200m investment in US cancer specialist - update
China-based Hopu Investments and YuanMing Capital have led a $200 million investment in US-based cancer treatment specialist Mevion Medical Systems.
Riverside invests in Australia’s IPAR Rehabilitation
The Riverside Company has acquired in IPAR Rehabilitation, an Australia-based provider of injury prevention and management and rehabilitation services that minimize the impact of workplace injury and illness.
PE backers set for partial exits in HealthCare Global's India IPO
HealthCare Global Enterprises (HCG), a private equity-backed Indian cancer care hospital chain, has filed for an IPO.
Deal focus: MedGenome aims to fill the sequencing gap
India's vast assortment of ethnic groups represents a golden opportunity for MedGenome. The 2,000 groups that inhabit the subcontinent are a treasure trove of information waiting to be harvested and put to work.
GSR, Go Scale raise $1b for M&A fund, seek to deploy $5b – update
GSR Capital and its affiliate Go Scale Capital has raised $1 billion for a cross-border buyout and M&A fund, which it hopes will translate into $5 billion worth of dry powder once debt financing and co-investment are factored in.
GGV leads round for China B2B drug retail platform
GGV Capital has led an extended Series A round of funding for Ypzdw.com, a Chinese online B2B drug retail platform. Existing investor Matrix Partners China also participated.
Sequoia commits $20m to Indian gene researcher MedGenome
Sequoia Capital has committed $20 million in Series B funding to Indian genomic diagnostic and research service provider MedGenome.
Vivo Capital leads Series B for China’s cosmetic surgery app
Healthcare specialist Vivo Capital has led a Series B round of funding for Gengmei, a Chinese cosmetic surgery social networking app, with participation from Sequoia Capital.
KKR supports Philippines social enterprise project
KKR has completed its second social enterprise assistance project alongside Impact Investment Exchange Asia (IIX) and its non-profit sister organization Shujog, providing support to Glovax Biotech, which sells affordable vaccines to low to middle income...